Replimune (REPL) Cash from Investing Activities (2017 - 2025)

Replimune has disclosed Cash from Investing Activities across 9 years of filings, most recently posting $75.1 million for Q4 2025.

• Cash from Investing Activities for Q4 2025 came in at $75.1 million, up 262.18% year-over-year; the trailing twelve-month figure through Dec 2025 was $216.6 million (up 2949.08% YoY), and the FY2025 annual result was -$23.8 million, down 124.48% from the prior year.
• Cash from Investing Activities came in at $75.1 million for Q4 2025 at Replimune, down from $84.2 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $84.2 million in Q3 2025 to a low of -$126.3 million in Q1 2021.
• The 5-year median for Cash from Investing Activities is $2.9 million (2022), against an average of $1.4 million.
• Across the five-year window, Cash from Investing Activities slumped 1710.42% in 2021 and surged 35130.56% in 2023, its largest moves.
• Replimune's Cash from Investing Activities stood at -$13.4 million in 2021, then slumped by 832.2% to -$125.1 million in 2022, then surged by 143.13% to $54.0 million in 2023, then plunged by 185.85% to -$46.3 million in 2024, then soared by 262.18% to $75.1 million in 2025.
• The last three Cash from Investing Activities figures came in at $75.1 million (Q4 2025), $84.2 million (Q3 2025), and $65.0 million (Q2 2025), per Business Quant data.